A. Pavlova

发表

Living on the edge: Simulations of bacterial outer-membrane proteins.

James C Gumbart, Hyea Hwang, Anna Pavlova, 2016, Biochimica et biophysica acta.

Supercomputer-Based Ensemble Docking Drug Discovery Pipeline with Application to Covid-19

John A. Gunnels, Julie C. Mitchell, Matthew B. Baker, 2020, ChemRxiv.

Effect of F8 B domain gene variants on synthesis, secretion, activity and stability of factor VIII protein

J. Oldenburg, A. Pavlova, J. Driesen, 2013, Thrombosis and Haemostasis.

Impact of polymorphisms of the major histocompatibility complex class II, interleukin‐10, tumor necrosis factor‐α and cytotoxic T‐lymphocyte antigen‐4 genes on inhibitor development in severe hemophilia A

R. Fimmers, J. Astermark, S. Lacroix-Desmazes, 2009, Journal of thrombosis and haemostasis : JTH.

Inhibitor Binding Influences the Protonation State of Histidines in SARS-CoV-2 Main Protease

Jerry M. Parks, Jeremy C. Smith, Callum J. Dickson, 2020, bioRxiv.

Insights into pathological mechanisms of missense mutations in C-terminal domains of von Willebrand factor causing qualitative or quantitative von Willebrand disease

A. Biswas, J. Oldenburg, A. Pavlova, 2013, Haematologica.

Structural insight into proteorhodopsin oligomers.

Songi Han, A. Pavlova, Matthias J. N. Junk, 2013, Biophysical journal.

Toward the rational design of macrolide antibiotics to combat resistance

Jerry M. Parks, J. Gumbart, J. Parks, 2017, Chemical biology & drug design.

Heterozygous large deletions of Factor 8 gene in females identified by multiplex PCR‐LC

J. Oldenburg, O. el-Maarri, D. Delev, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

Simulation-Based Approaches for Determining Membrane Permeability of Small Compounds

Yi Wang, Robert V. Swift, Rommie E. Amaro, 2016, J. Chem. Inf. Model..

Clarifying the role of sodium in the silica oligomerization reaction.

T. Trinh, A. Pavlova, R. V. van Santen, 2013, Physical chemistry chemical physics : PCCP.

Machine Learning Reveals the Critical Interactions for SARS-CoV-2 Spike Protein Binding to ACE2

Jerry M. Parks, C. Chipot, J. Gumbart, 2021, Biophysical Journal.

F8 Inversions at Xq28 Causing Hemophilia A Are Associated With Specific Methylation Changes: Implication for Molecular Epigenetic Diagnosis

M. Jamil, Amit Sharma, J. Oldenburg, 2019, Front. Genet..

In silico and in vitro evaluation of the impact of mutations in non-severe haemophilia A patients on assay discrepancies

A. Biswas, H. Singer, J. Oldenburg, 2019, Annals of Hematology.

Haemophilia A mutations in patients with non-severe phenotype associated with a discrepancy between one-stage and chromogenic factor VIII activity assays

J. Oldenburg, D. Delev, A. Pavlova, 2014, Thrombosis and Haemostasis.

Parameterization of a drug molecule with a halogen σ-hole particle using ffTK: Implementation, testing, and comparison.

E. Tajkhorshid, J. Gumbart, A. Pavlova, 2020, The Journal of chemical physics.

Variability in Clinical Phenotype of Hemophilia : Role of the F 8 / F 9 Genotype

J. Oldenburg, A. Pavlova, 2013 .

Tubular Localization and Tissue Distribution of Peptide Transporters in Rat Kidney

M. Hediger, Tianxin Yang, A. Pavlova, 1998, Pharmaceutical Research.

Skewed X-chromosome inactivation and XIST locus methylation levels do not contribute to the lower prevalence of Parkinson's disease in females

H. Fröhlich, Amit Sharma, J. Oldenburg, 2017, Neurobiology of Aging.

Supercomputer-Based Ensemble Docking Drug Discovery Pipeline with Application to Covid-19

John A. Gunnels, Julie C. Mitchell, Matthew B. Baker, 2020, Journal of chemical information and modeling.

Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).

J. Oldenburg, A. Pavlova, A. Hochhaus, 2007, Blood.

Genetic markers in acquired haemophilia

J. Oldenburg, A. Pavlova, H. Zeitler, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

Development of CHARMM-Compatible Force-Field Parameters for Cobalamin and Related Cofactors from Quantum Mechanical Calculations.

Jerry M. Parks, J. Gumbart, J. Parks, 2018, Journal of chemical theory and computation.

Supercomputer-Based Ensemble Docking Drug Discovery Pipeline with Application to Covid-19

Duncan Poole, John A. Gunnels, Arvind Ramanathan, 2020, J. Chem. Inf. Model..

Variants in FIX propeptide associated with vitamin K antagonist hypersensitivity: functional analysis and additional data confirming the common founder mutations

J. Oldenburg, A. Pavlova, S. Ulrich, 2018, Annals of Hematology.

Differential expression patterns of Wnt genes in the murine female reproductive tract during development and the estrous cycle

D. Sassoon, A. Pavlova, Cary Miller, 1998, Mechanisms of Development.

Msx1 (Hox-7.1) in the adult mouse uterus: cellular interactions underlying regulation of expression.

D. Sassoon, A. Pavlova, G. Cunha, 1994, Development.

Development of inhibitory antibodies to therapeutic factor VIII in severe hemophilia A is associated with microsatellite polymorphisms in the HMOX1 promoter

S. Kaveri, S. Lacroix-Desmazes, J. Dimitrov, 2013, Haematologica.

HLA genotype in patients with acquired haemophilia A

J. Oldenburg, A. Pavlova, H. Brackmann, 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

HLA Profile in Acquired Hemophilia

E. Seifried, J. Oldenburg, A. Pavlova, 2005 .

Blood Coagulation , Fibrinolysis and Cellular Haemostasis Molecular basis of antithrombin deficiency

E. Seifried, J. Oldenburg, D. Delev, 2018 .

Factor 5 mutation profile in German patients with homozygous and heterozygous factor V deficiency

E. Seifried, J. Oldenburg, D. Delev, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Immune Tolerance Induction (ITI) with a pdFVIII/VWF Concentrate (octanate) in 100 Patients in the Observational ITI (ObsITI) Study

V. Jiménez‐Yuste, A. Pavlova, V. Vdovin, 2022, TH open : companion journal to thrombosis and haemostasis.

The role of variant alleles of the mannose-binding lectin in the inhibitor development in severe hemophilia A.

J. Oldenburg, A. Pavlova, G. Ulrich-Merzenich, 2019, Thrombosis research.

Molecular mechanisms underlying hemophilia A phenotype in seven females

J. Oldenburg, A. Pavlova, A. Srivastava, 2009, Journal of thrombosis and haemostasis : JTH.

Blood Coagulation, Fibrinolysis and Cellular Haemostasis Deficiencies of antithrombin, protein C and protein S – Practical experience in genetic analysis of a large patient cohort

J. Oldenburg, A. Pavlova, J. Driesen, 2017 .

Synergistic Biophysical Techniques Reveal Structural Mechanisms of Engineered Cationic Antimicrobial Peptides in Lipid Model Membranes.

A. Salyapongse, J. Gumbart, D. Huster, 2020, Chemistry.

Genomics of bleeding disorders

J. Oldenburg, A. Pavlova, A. Goodeve, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Philadelphia-positive acute lymphoblastic leukemia ( Ph imatinib-based therapy and give rise to relapse in patients with de novo Kinase domain mutations of BCR-ABL frequently precede

J. Oldenburg, A. Pavlova, A. Hochhaus, 2007 .

Pseudo-Homozygous APC Resistance Due to Coinheritance of Heterozygous Factor V — R506Q and Type I Deficiency Associated with Thrombosis

J. Oldenburg, D. Delev, A. Pavlova, 2008 .

Identification and functional characterization of a novel F5 mutation (Ala512Val, FVBonn) associated with activated protein C resistance

A. Biswas, J. Oldenburg, A. Pavlova, 2016, Journal of thrombosis and haemostasis : JTH.

Defining Severity of Hemophilia: More than Factor Levels

J. Oldenburg, A. Pavlova, 2013, Seminars in Thrombosis & Hemostasis.

Discrepancy between one-stage and chromogenic factor VIII activity assay results can lead to misdiagnosis of haemophilia A phenotype

J. Oldenburg, A. Pavlova, 2010, Hämostaseologie.

Developmentally regulated expression of organic ion transporters NKT (OAT1), OCT1, NLT (OAT2), and Roct.

D. Beier, A. Yu, A. Pavlova, 2000, American journal of physiology. Renal physiology.

Genetic risk factors for inhibitors to factors VIII and IX

J. Oldenburg, A. Pavlova, A. Pavlova, 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

A novel fibrinogen γ chain frameshift deletion (c.637delT) in a patient with hypodysfibrinogenemia associated with thrombosis.

A. Biswas, J. Oldenburg, A. Pavlova, 2015, Hamostaseologie.

Large deletions identified in patients with von Willebrand disease using multiple ligation‐dependent probe amplification

J. Oldenburg, A. Pavlova, J. Driesen, 2011, Journal of thrombosis and haemostasis : JTH.

First Case of Compound Heterozygous Mutations in the Kininogen Gene Causing Severe High Molecular Weight Kininogen Deficiency

E. Seifried, J. Oldenburg, C. Geisen, 2005 .

In silico calculated affinity of FVIII‐derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene

S. Kaveri, S. Lacroix-Desmazes, J. Oldenburg, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

PC Deficiency Testing: Thrombin-Thrombomodulin as PC Activator and Aptamer-Based Enzyme Capturing Increase Diagnostic Accuracy

J. Oldenburg, A. Pavlova, Jens Müller, 2021, Frontiers in Cardiovascular Medicine.

Congenital combined deficiency of coagulation factors VII and X – different genetic mechanisms

J. Oldenburg, A. Pavlova, J. Driesen, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Molecular analysis of FVIII gene in severe HA patients of Costa Rica.

J. Oldenburg, A. Pavlova, K. Wulff, 2010, Hamostaseologie.

Molecular genetic background of haemophilia A patients with discrepancy between one-stage and two-stage factor VIII assays

J. Oldenburg, D. Delev, A. Pavlova, 2010 .

A Novel Bruton’s Tyrosine Kinase Mutation in Russian Patient with X-Linked Agammaglobulinemia

I. Tuzankina, M. Bolkov, A. Pavlova, 2017 .

Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation

Weining Lu, Jing Zhou, G. Brent, 1997, Nature Genetics.

Bis(di-2-pyridylamine-kappa2N2,N2')(nitrato-kappa2O,O')nickel(II) nitrate.

A. Pavlova, M. Dušek, K. Fejfarová, 2009, Acta crystallographica. Section C, Crystal structure communications.

Recommendations for clinical laboratory testing for protein C deficiency, for the subcommittee on plasma coagulation inhibitors of the ISTH

R. Marlar, A. Pavlova, G. Moore, 2020, Journal of thrombosis and haemostasis : JTH.

Functional Characterization of Antithrombin Mutations by Monitoring of Thrombin Inhibition Kinetics

J. Oldenburg, A. Pavlova, B. Pezeshkpoor, 2021, International journal of molecular sciences.

Anion-exchange HPLC assay for separation and quantification of empty and full capsids in multiple adeno-associated virus serotypes

Santoshkumar L. Khatwani, A. Pavlova, Z. Pirot, 2021, Molecular therapy. Methods & clinical development.

Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study

E. Neufeld, J. Oldenburg, V. Jiménez‐Yuste, 2021, Thrombosis and Haemostasis.

Immunogenicity, efficacy and safety of Nuwiq® (human‐cl rhFVIII) in previously untreated patients with severe haemophilia A—Interim results from the NuProtect Study

E. Neufeld, T. Lambert, M. Carcao, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Achievements, challenges and unmet needs for haemophilia patients with inhibitors

D. Scott, David Steven Scott, S. Lacroix-Desmazes, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study

J. Oldenburg, V. Jiménez‐Yuste, A. Pavlova, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Beyond the bleeding rates‐ HEAD‐US joint assessment in patients treated by late prophylaxis

A. Pavlova, S. Kostova, N. Petkova, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Low incidence of factor VIII inhibitors in previously untreated patients with severe haemophilia A treated with octanate®: Final report from a prospective study

A. Pavlova, A. Klukowska, V. Komrska, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A.

J. Astermark, J. Oldenburg, A. Pavlova, 2006, Blood.

Polymorphisms in the IL-10 but not in the IL-1{beta} and IL-4 genes are associated with inhibitor development in patients with hemophilia A.

J. Astermark, J. Oldenburg, A. Pavlova, 2006 .

The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

C. Winkler, J. Astermark, B. Kessing, 2013, Blood.

F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort

M. Carrington, C. Winkler, J. Astermark, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Familial Multiple Coagulation Factor Deficiencies (FMCFDs) in a Large Cohort of Patients—A Single-Center Experience in Genetic Diagnosis

J. Oldenburg, A. Pavlova, S. Unal, 2021, Journal of clinical medicine.

F8 gene and phenotype: single player in a team?

A. Pavlova, 2013, Blood.

Significance of F8 missense mutations with respect to inhibitor formation

J. Oldenburg, A. Pavlova, R. Schwaab, 2013, Thrombosis and Haemostasis.

Increased frequency of the CTLA‐4 49 A/G polymorphism in patients with acquired haemophilia A compared to healthy controls

T. Wienker, A. Hoerauf, J. Oldenburg, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

Insights into the Molecular Genetic of Hemophilia A and Hemophilia B: The Relevance of Genetic Testing in Routine Clinical Practice

J. Oldenburg, A. Pavlova, B. Pezeshkpoor, 2022, Hämostaseologie.

Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients

A. Biswas, J. Oldenburg, A. Pavlova, 2012, Thrombosis and Haemostasis.

Role of factor VIII-binding capacity of endogenous von Willebrand factor in the development of factor VIII inhibitors in patients with severe hemophilia A

V. Ramanan, F. Rosendaal, S. Kaveri, 2019, Haematologica.

Historical Review on Genetic Analysis in Hemophilia A

J. Oldenburg, A. Pavlova, B. Pezeshkpoor, 2014, Seminars in Thrombosis & Hemostasis.

Identification of a novel factor X deletion in combination with a missense mutation in the F10 gene

J. Oldenburg, I. Hainmann, A. Pavlova, 2009, Hämostaseologie.

F8 genetic analysis strategies when standard approaches fail

J. Oldenburg, O. el-Maarri, A. Pavlova, 2013, Hämostaseologie.

A novel two-dimensional Ni(II) fumarato complex: Solvothermal synthesis, crystal structure and magnetic properties

A. Pavlova, A. Orendáčová, M. Kajňaková, 2009 .

catena-Poly[[[diaqua(di-2-pyridylamine-κ2 N,N′)nickel(II)]-μ-fumarato-κ2 O 1:O 4] tetrahydrate]

Juraj Černák, Klaus Harms, Anna Pavlová, 2010, Acta crystallographica. Section E, Structure reports online.

Understanding the role of water in aqueous ruthenium-catalyzed transfer hydrogenation of ketones.

A. Pavlova, E. Meijer, 2012, Chemphyschem : a European journal of chemical physics and physical chemistry.

Mechanistic Aspects of Using Formate as a Hydrogen Donor in Aqueous Transfer Hydrogenation

A. Pavlova, E. Meijer, Ernst Rösler, 2016 .

Quantitative cw Overhauser effect dynamic nuclear polarization for the analysis of local water dynamics.

Songi Han, Anna Pavlova, Songi Han, 2013, Progress in nuclear magnetic resonance spectroscopy.

Resolving the Hydride Transfer Pathway in Oxidative Conversion of Proline to Pyrrole.

J. Gumbart, A. Pavlova, Dongqi Yi, 2021, Biochemistry.

Redox-Driven Conformational Dynamics in a Photosystem-II-Inspired β-Hairpin Maquette Determined through Spectroscopy and Simulation.

C. Pagba, J. Gumbart, A. Pavlova, 2017, The journal of physical chemistry. B.

Critical interactions for SARS-CoV-2 spike protein binding to ACE2 identified by machine learning

Jerry M. Parks, C. Chipot, J. Gumbart, 2021, bioRxiv.

Evolution of gene expression patterns in a model of branching morphogenesis.

R. O. Stuart, A. Pavlova, S. Nigam, 1999, American journal of physiology. Renal physiology.

Evolution of gene expression patterns in a model of branching morphogenesis.

R. O. Stuart, A. Pavlova, S. Nigam, 1999, The American journal of physiology.

EEG1, a putative transporter expressed during epithelial organogenesis: comparison with embryonic transporter expression during nephrogenesis.

D. Beier, R. O. Stuart, A. Pavlova, 2001, American journal of physiology. Renal physiology.

Runcer-Necromancer: A Method To Rescue Data From An Interrupted Run On MGISEQ-2000

Anna Pavlova, Vera Belova, Robert Afasizhev, 2020, bioRxiv.

Deletion of human GP 1 BB and SEPT 5 is associated with Bernard-Soulier syndrome , platelet secretion defect , polymicrogyria , and develop-mental delay

P. Nurden, J. Oldenburg, I. Hainmann, 2018 .

Detection of heterozygous large deletions in the antithrombin gene using multiplex polymerase chain reaction and denatured high performance liquid chromatography.

E. Seifried, J. Oldenburg, O. el-Maarri, 2006, Haematologica.

System analysis of the sequencing quality of human whole exome samples on BGI NGS platform

A. Pavlova, D. Rebrikov, D. Korostin, 2021, Scientific Reports.

Blood Coagulation , Fibrinolysis and Cellular Haemostasis Molecular basis of antithrombin deficiency

E. Seifried, J. Oldenburg, D. Delev, 2012 .

Experiences in Routine Genetic Analysis of Hereditary Hemorrhagic, Thrombotic, and Platelet Disorders.

A. Pavlova, B. Pezeshkpoor, J. Oldenburg, 2022, Hamostaseologie.

Modelling and expression studies of two novel mutations causing factor V deficiency

E. Seifried, Tamir Chandra, J. Oldenburg, 2008, Thrombosis and Haemostasis.

Parametrization of macrolide antibiotics using the force field toolkit

Anna Pavlova, James C Gumbart, J. Gumbart, 2015, J. Comput. Chem..

Inhibitor binding influences the protonation states of histidines in SARS-CoV-2 main protease

Callum J. Dickson, C. Chipot, J. Gumbart, 2020, Chemical science.

Risk stratification integrating genetic data for factor VIII inhibitor development in patients with severe hemophilia A

C. Königs, P. Dönnes, S. Lacroix-Desmazes, 2019, PloS one.

Protein structural and surface water rearrangement constitute major events in the earliest aggregation stages of tau

Songi Han, Anna Pavlova, F. Dahlquist, 2015, Proceedings of the National Academy of Sciences.

Pattern and Evolution of BCR-ABL Kinase Domain Mutations in Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Developing Resistance to Imatinib.

J. Oldenburg, H. Gschaidmeier, A. Pavlova, 2005 .

SARS-CoV-2 spike opening dynamics and energetics reveal the individual roles of glycans and their collective impact

J. Gumbart, A. Pavlova, D. Lynch, 2021, bioRxiv.

Detection of large duplications within the factor VIII gene by MLPA 1

J. Oldenburg, A. Pavlova, S. Rost, 2008, Journal of thrombosis and haemostasis : JTH.

Diverse Protein-Folding Pathways and Functions of β-Hairpins and β-Sheets

J. Gumbart, A. Pavlova, Hyea Hwang, 2018 .

Deletion of human GP1BB and SEPT5 is associated with Bernard-Soulier syndrome, platelet secretion defect, polymicrogyria, and developmental delay

P. Nurden, J. Oldenburg, I. Hainmann, 2011, Thrombosis and Haemostasis.

Comparison of Pkd1-targeted mutants reveals that loss of polycystin-1 causes cystogenesis and bone defects.

P. Harris, C. Ward, A. Perez-Atayde, 2001, Human molecular genetics.

Targeted Resequencing of 29 Candidate Genes and Mouse Expression Studies Implicate ZIC3 and FOXF1 in Human VATER/VACTERL Association

M. Nöthen, O. el-Maarri, F. Hildebrandt, 2015, Human mutation.

Probing the hydration water diffusion of macromolecular surfaces and interfaces

J. Ortony, Songi Han, Ravinath Kausik, 2011 .

Distribution and developmentally regulated expression of murine polycystin.

Weining Lu, Jing Zhou, A. Pavlova, 1997, The American journal of physiology.

NOTCH4 gene polymorphisms as potential risk factors for brain arteriovenous malformation development and hemorrhagic presentation.

R. Fimmers, J. Schramm, A. Boström, 2017, Journal of neurosurgery.

Trypanosoma brucei Methylthioadenosine Phosphorylase Protects the Parasite from the Antitrypanosomal Effect of Deoxyadenosine

H. D. de Koning, A. Pavlova, M. Vodnala, 2016, The Journal of Biological Chemistry.

SNP Map of the Protein C Gene

E. Seifried, J. Oldenburg, C. Geisen, 2005 .

Tuning Proton Transfer Thermodynamics in SARS-CoV-2 Main Protease: Implications for Catalysis and Inhibitor Design

Jeremy C. Smith, C. Chipot, J. Gumbart, 2021, The journal of physical chemistry letters.

Accelerating Membrane Simulations with Hydrogen Mass Repartitioning.

J. Gumbart, A. Pavlova, Hyea Hwang, 2019, Journal of chemical theory and computation.

ACE2 glycans preferentially interact with SARS-CoV-2 over SARS-CoV.

J. Gumbart, A. Pavlova, D. Lynch, 2021, Chemical communications.

Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency

E. Seifried, C. Geisen, A. Pavlova, 2013, Thrombosis and Haemostasis.

Tuning proton transfer thermodynamics in SARS-Cov-2 main protease: implications for catalysis and inhibitor design

Jeremy C. Smith, C. Chipot, J. Gumbart, 2020, ChemRxiv : the preprint server for chemistry.

Bis(2,2′-bipyridine-κ2 N,N′)(maleato-κ2 O 1,O 1′)nickel(II) 7.34-hydrate

Juraj Černák, Klaus Harms, Anna Pavlová, 2008, Acta crystallographica. Section E, Structure reports online.

Type 2B von Willebrand Disease: Early Manifestation as Neonatal Thrombocytopenia.

J. Oldenburg, A. Pavlova, B. Zieger, 2021, Hamostaseologie.

Site-specific dynamic nuclear polarization of hydration water as a generally applicable approach to monitor protein aggregation.

F. Dahlquist, Songi Han, E. McCarney, 2009, Physical chemistry chemical physics : PCCP.

Characterization of the mutation spectrum in a Pakistani cohort of type 3 von Willebrand disease

A. Biswas, J. Oldenburg, A. Pavlova, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Genetic Basis for Inhibitor Development

J. Oldenburg, A. Pavlova, 2011 .

Identification of a novel large deletion in a patient with severe factor V deficiency using an in‐house F5 MLPA assay

S. Duga, A. Pavlova, E. Paraboschi, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

In vitro characterization of recombinant factor VIII concentrates reveals significant differences in protein content, activity and thrombin activation profile

J. Oldenburg, A. Pavlova, J. Driesen, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Mechanism of action of HBV capsid assembly modulators predicted from binding to early assembly intermediates

C. Chipot, R. Schinazi, J. Gumbart, 2020, bioRxiv.

Quantitative cw Overhauser DNP Analysis of Hydration Dynamics

Songi Han, A. Pavlova, J. Franck, 2012, 1206.0510.

Blood Coagulation, Fibrinolysis and Cellular Haemostasis Deficiencies of antithrombin, protein C and protein S – Practical experience in genetic analysis of a large patient cohort

J. Oldenburg, A. Pavlova, J. Driesen, 2017 .

ACE2 glycans preferentially interact with the RBD of SARS-CoV-2 over SARS-CoV

J. Gumbart, A. Pavlova, D. Lynch, 2021, bioRxiv.

Factor 5 mutation profile in German patients with homozygous and heterozygous factor V deficiency

E. Seifried, J. Oldenburg, D. Delev, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Blood Coagulation, Fibrinolysis and Cellular Haemostasis Deficiencies of antithrombin, protein C and protein S – Practical experience in genetic analysis of a large patient cohort

J. Oldenburg, A. Pavlova, J. Driesen, 2017 .